| Speakers and Topics: |
Where will the next antibiotics come from – big Pharma or Biotech?, Clarence D. Young, MD, Chief Medical Officer, Protez Pharmaceuticals, Inc.
How many rapid diagnostic technologies impact ID drug development and use?, David Melnick, MD, Senior Director Medical Science, Clinical Oncology, AstraZeneca |